OPA1 mutations can cause dominant optic atrophy [9,10], while many MFN2 mutations cause the peripheral sensory–motor neuropathy Charcot–Marie–Tooth disease type 2A (CMT2A) [7,8,11]. The gene discussed is MFN2; the disease is Charcot-Marie-Tooth disease type 2A1.